Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4

Fig. 2

Binding properties of the nanobodies, as analysed by flow cytometry. a AsPC-1 and Panc-1 cells were stained with parental Nb PD-L1 and Nb CXCR4. b Analysis of BsNb PX4-induced cellular clustering when U251-MG cells and Jurkat cells were mixed at a 1:1 ratio. Quantification of the flow cytometry results showing the percentage of events that represent cellular clusters. c Curve showing BsNb PX4, Nb PD-L1, Nb CXCR4 binding with PD-L1+U251-MG or CXCR4+ Jurkat cells

Back to article page